FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 100 mg/5 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | 500 mg/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-020 | 71506-020-56 | Calcium Gluconate | 1 g/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 750 mg/250 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | 1 g/250 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2 g/500 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-021 | 71506-021-56 | Calcium Gluconate | 2 g/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-011 | 71506-011-10 | Water | 10 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 15 mg/3 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-060 | 71506-060-58 | Epinephrine | 8 mg/250 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-035 | 71506-035-56 | Acyclovir Sodium | 200 mg/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-023 | 71506-023-03 | Glycopyrrolate | .6 mg/3 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 1000 mg/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 50 mg/5 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 100 mg/10 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 10 mg/1 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 100 mg/5 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-042 | 71506-042-56 | Midazolam Hydrochloride | 100 mg/100 mL | 2022-1 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-036 | 71506-036-01 | Atropine Sulfate | .4 mg/1 mL | 2022-1 | valid | 2026-11-12 | ||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Triamcinolone Acetonide; Moxifloxacin Hydrochloride | 15 mg/1 mL; 1 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ascorbic Acid | 500 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | .6 mg/.6 mL; 9 mg/.6 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-1 | source_no_ndc | 2026-11-12 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2022-1 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2022-1 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7153 | 71139-7153-1 | Cefazolin Sodium | 3 g/123 mL | 2022-1 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2 g/20 mL | 2022-1 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5330 | 71139-5330-1 | Cefazolin Sodium | 3 g/30 mL | 2022-1 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6643 | 71139-6643-1 | Ephedrine Sulfate | 25 mg/5 mL | 2022-1 | valid | 2026-11-12 |